PL3869199T3 - Sposób i reagenty do diagnozowania SARS-CoV-2 - Google Patents

Sposób i reagenty do diagnozowania SARS-CoV-2

Info

Publication number
PL3869199T3
PL3869199T3 PL20215445T PL20215445T PL3869199T3 PL 3869199 T3 PL3869199 T3 PL 3869199T3 PL 20215445 T PL20215445 T PL 20215445T PL 20215445 T PL20215445 T PL 20215445T PL 3869199 T3 PL3869199 T3 PL 3869199T3
Authority
PL
Poland
Prior art keywords
cov
sars
reagents
diagnosis
Prior art date
Application number
PL20215445T
Other languages
English (en)
Inventor
Katja STEINHAGEN
Claudia MESSING
Erik LATTWEIN
Konstanze Stiba
Fabian LINDHORST
Eva Neugebauer
Marcel Müller
Victor CORMAN
Original Assignee
Euroimmun Medizinische Labordiagnostika Ag
Charité - Universitätsmedizin Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69726444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3869199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euroimmun Medizinische Labordiagnostika Ag, Charité - Universitätsmedizin Berlin filed Critical Euroimmun Medizinische Labordiagnostika Ag
Publication of PL3869199T3 publication Critical patent/PL3869199T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL20215445T 2020-02-20 2020-02-20 Sposób i reagenty do diagnozowania SARS-CoV-2 PL3869199T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20158626.0A EP3715847A1 (en) 2020-02-20 2020-02-20 A method and reagents for the diagnosis of sars-cov-2
EP20215445.6A EP3869199B1 (en) 2020-02-20 2020-02-20 A method and reagents for the diagnosis of sars-cov-2

Publications (1)

Publication Number Publication Date
PL3869199T3 true PL3869199T3 (pl) 2022-05-30

Family

ID=69726444

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20215445T PL3869199T3 (pl) 2020-02-20 2020-02-20 Sposób i reagenty do diagnozowania SARS-CoV-2

Country Status (10)

Country Link
EP (3) EP3869200A1 (pl)
DE (1) DE20158626T1 (pl)
DK (1) DK3869199T3 (pl)
ES (2) ES2788459T1 (pl)
HR (1) HRP20220373T1 (pl)
HU (1) HUE058338T2 (pl)
LT (1) LT3869199T (pl)
PL (1) PL3869199T3 (pl)
PT (1) PT3869199T (pl)
SI (1) SI3869199T1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102021003012A2 (pt) 2020-02-19 2021-11-30 Univ Berlin Charite Métodos para o diagnóstico de infecção por sars-cov-2, kit e usos
EP3869200A1 (en) 2020-02-20 2021-08-25 Euroimmun Medizinische Labordiagnostika AG A method and reagents for the diagnosis of sars-cov-2
WO2021186029A1 (en) * 2020-03-20 2021-09-23 Deutsches Krebsforschungszentrum Sars spike peptides and uses thereof
GB202006815D0 (en) * 2020-05-07 2020-06-24 Senseutics Ltd Method
US20250195501A1 (en) * 2020-05-07 2025-06-19 Griffith University Cell entry-modulating agents and uses therefor
EP3734286A1 (en) 2020-05-15 2020-11-04 Euroimmun Medizinische Labordiagnostika AG A method for determining the efficacy of a sars-cov-2 vaccine
CN111551715B (zh) * 2020-05-18 2022-04-22 天津博奥赛斯生物科技股份有限公司 一种新型冠状病毒IgM抗体的酶联免疫法检测试剂盒
EP3913369A1 (en) * 2020-05-20 2021-11-24 Diesse Diagnostica Senese S.p.a. Method for inactivating sars-cov-2 and uses thereof
CN111848753B (zh) * 2020-07-20 2022-03-15 中国科学院过程工程研究所 新型冠状病毒抗原表位及其应用
CN117986358B (zh) * 2020-08-19 2025-01-24 重庆医科大学 新冠病毒rbd特异性单克隆抗体和应用
DE102020125915B3 (de) 2020-10-02 2022-03-03 Institut für Molekulare Diagnostik und Bioanalytik Immundiagnostische mittel und verfahren für den nachweis und die differenzierung von coronavirus-infektionen
CN112251414A (zh) * 2020-10-12 2021-01-22 中国科学院苏州纳米技术与纳米仿生研究所 一种杂交瘤细胞株、其制备方法和应用
KR20220054080A (ko) * 2020-10-23 2022-05-02 주식회사 와이바이오로직스 SARS-CoV-2 스파이크 단백질에 특이적으로 결합하는 항체 및 이의 용도
TW202237626A (zh) * 2020-11-12 2022-10-01 美商帝斯肯醫療公司 Ｓａｒｓ－ｃｏｖ－２免疫顯性肽構築體及其用途
WO2022109751A1 (en) * 2020-11-27 2022-06-02 The University Of Western Ontario Point-of-care testing for sars-cov antibodies
US20240226272A9 (en) * 2020-12-18 2024-07-11 The Scripps Research Institute Immunogenic compositions
CN112611870B (zh) * 2020-12-21 2022-09-16 杭州宝临生物科技有限公司 预测新型冠状病毒中和抗体效价的方法及其试剂盒
CN112379090B (zh) * 2021-01-07 2021-04-16 北京百普赛斯生物科技股份有限公司 新型冠状病毒抗体检测试剂盒及其制备方法与应用
CN112946261A (zh) * 2021-01-14 2021-06-11 广州中医药大学顺德医院(佛山市顺德区中医院) 一种基于三聚体s蛋白rbd-ace2结合竞争的新冠病毒中和抗体检测试剂盒
US20240301037A1 (en) * 2021-01-22 2024-09-12 La Jolla Institute For Immunology Chimeric anti-coronavirus spike protein antibodies
CN112415189B (zh) * 2021-01-22 2021-03-30 北京百普赛斯生物科技股份有限公司 偶联新型冠状病毒s2蛋白的磁珠及其制备方法与应用
CN113278067B (zh) * 2021-02-09 2022-06-28 武汉中生毓晋生物医药有限责任公司 一种新型冠状病毒猪源性免疫球蛋白的制备方法
CN113238046A (zh) * 2021-04-30 2021-08-10 深圳迈瑞生物医疗电子股份有限公司 检测冠状病毒抗体的试剂盒、冠状病毒抗体的检测方法
CN114371159B (zh) * 2021-05-19 2023-11-07 南京医科大学第二附属医院 一种rna生物芯片及其制备方法与应用
CN114231497B (zh) * 2022-02-24 2022-05-20 广州伯尼兹生物科技有限公司 一株表达SARS-CoV-2 S1蛋白单克隆抗体杂交瘤细胞系及中和活性抗体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200510450A (en) 2003-07-21 2005-03-16 Nat Inst Health Soluble fragments of the SARS-CoV spike glycoprotein
US20050112559A1 (en) * 2003-09-29 2005-05-26 The Chinese University Of Hong Kong Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
WO2005032487A2 (en) 2003-10-06 2005-04-14 The Brigham And Women's Hospital, Inc. Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus
US7491397B2 (en) 2004-01-09 2009-02-17 National Health Research Institutes Receptor binding polypeptides
CA2568838A1 (en) * 2004-06-04 2005-12-15 Institut Pasteur Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
US20060188519A1 (en) * 2004-06-14 2006-08-24 To Cheung Peptides, antibodies, and methods for the diagnosis of SARS
US20080269115A1 (en) * 2004-06-17 2008-10-30 Beadenkopf Robert J Immunogenic Sars Domain
US10781426B2 (en) 2012-09-23 2020-09-22 Erasmus University Medical Center Rotterdam Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor
EP3869200A1 (en) 2020-02-20 2021-08-25 Euroimmun Medizinische Labordiagnostika AG A method and reagents for the diagnosis of sars-cov-2

Also Published As

Publication number Publication date
ES2910184T3 (es) 2022-05-11
LT3869199T (lt) 2022-07-11
EP3715847A1 (en) 2020-09-30
SI3869199T1 (sl) 2022-05-31
EP3869200A1 (en) 2021-08-25
HRP20220373T1 (hr) 2022-05-13
DK3869199T3 (da) 2022-03-07
PT3869199T (pt) 2022-03-02
ES2788459T1 (es) 2020-10-21
DE20158626T1 (de) 2020-12-10
HUE058338T2 (hu) 2022-07-28
EP3869199B1 (en) 2022-02-09
EP3869199A1 (en) 2021-08-25

Similar Documents

Publication Publication Date Title
PL3869199T3 (pl) Sposób i reagenty do diagnozowania SARS-CoV-2
EP3761860A4 (en) AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND PROCESS
IL287182A (en) A system and method for detecting cognitive decline using speech analysis
HUE062070T2 (hu) Eszköz és eljárás akkumulátor SOH állapotának elemzésére
PL3702238T3 (pl) System diagnostyczny i sposób diagnozowania usterek
ZA202208804B (en) A method of measuring the ph of a sample
EP3762921A4 (en) AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND PROCESS
IL293250B1 (en) System and method for defining flexible regions in a sample during testing
GB202000926D0 (en) Method of diagnosis
GB202105867D0 (en) Method of developing and using a tool and the resulting tool, for automating complex processes
IL299118A (en) Analytical sensor A method for producing an analytical sensor
GB202207821D0 (en) Methods and systems for automated clinical workflows
EP3847457A4 (en) BODY FLUID TESTING PROCEDURE
EP3762928A4 (en) AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND METHOD
GB202000634D0 (en) Diagnostic method
SI3948406T1 (sl) Sistem in metoda za izboljšanje ali rehabilitacijo kognitivnih spretnosti subjekta
SG10201900431QA (en) A sterile reagent preparation device and the method of using the same
GB201914089D0 (en) Apparatus and method for determining a biological characteristic
GB202102823D0 (en) Diagnostic method
EP4137046C0 (en) ANALYTE SENSOR AND PROCESS FOR PRODUCING THE SAME
GB202008994D0 (en) Assay method
PL3930598T3 (pl) Instrument medyczny i sposób wytwarzania instrumentu medycznego
ES3064017T3 (en) B-pillar and corresponding manufacturing method
GB2584806B (en) Diagnostic system and a method of diagnosing faults
GB202111998D0 (en) Diagnostic method